Literature DB >> 2494874

Plasma norepinephrine in Chagas' cardioneuromyopathy: a marker of progressive dysautonomia.

D Iosa1, V DeQuattro, D D Lee, U Elkayam, H Palmero.   

Abstract

Chronic Chagas' disease produces pathologic changes of the cardiovascular, digestive, and autonomic nervous systems. In an attempt to elucidate the nature of the dysautonomia in patients with Chagas' disease, we measured plasma norepinephrine levels, blood pressure, and heart rate, both supine and standing in 26 patients, and compared these values of patients classified according to three clinical subsets of cardiovascular manifestations with the values of nine normal volunteers and 16 patients with nonchagasic heart failure. Results suggested (1) progressive blockade of the alpha receptor in patients with Chagas' disease who have minimal clinical symptoms (group I) and in those who have ECG alterations without congestive symptoms (group II), as reflected by normal or raised plasma norepinephrine levels without change of diastolic blood pressure during standing, which indicates absent postural reflexes; and (2) blockade associated with partial denervation in patients with Chagas' disease who have class III or IV heart failure (group III), as suggested by a lower supine plasma norepinephrine level and a fall in diastolic blood pressure in the upright position. The findings of reduced plasma norepinephrine levels are in contrast to the elevated plasma norepinephrine levels in patients without Chagas' disease with class III and IV heart failure who have sympathetic hyperactivity.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2494874     DOI: 10.1016/0002-8703(89)90627-3

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  6 in total

1.  Parasympathetic denervation of the iris in Chagas' disease.

Authors:  J Idiaquez
Journal:  Clin Auton Res       Date:  1992-08       Impact factor: 4.435

2.  Ventricular tachycardia during exercise testing as a predictor of sudden death in patients with chronic chagasic cardiomyopathy and ventricular arrhythmias.

Authors:  A A de Paola; J A Gomes; A B Terzian; M H Miyamoto; E E Martinez Fo
Journal:  Br Heart J       Date:  1995-09

Review 3.  Chagas' disease.

Authors:  H B Tanowitz; L V Kirchhoff; D Simon; S A Morris; L M Weiss; M Wittner
Journal:  Clin Microbiol Rev       Date:  1992-10       Impact factor: 26.132

4.  Chronotropic incompetence and abnormal autonomic modulation in ambulatory Chagas disease patients.

Authors:  Ana Luiza Lunardi Rocha; Federico Lombardi; Manoel Otávio da Costa Rocha; Márcio Vinícius Lins Barros; Vladimir da Costa Val Barros; Adelina Martha Reis; Antonio Luiz Pinho Ribeiro
Journal:  Ann Noninvasive Electrocardiol       Date:  2006-01       Impact factor: 1.468

5.  Relationship between Urinary Norepinephrine, Fibrosis, and Arrhythmias in Chronic Chagas Heart Disease with Preserved or Mildly Reduced Ejection Fraction.

Authors:  Eduardo Marinho Tassi; Emília Matos do Nascimento; Marcelo Abramoff Continentino; Basilio de Bragança Pereira; Roberto Coury Pedrosa
Journal:  Arq Bras Cardiol       Date:  2022-07       Impact factor: 2.667

6.  Cardiac autonomic control mechanisms in the pathogenesis of chagas' heart disease.

Authors:  Diego F Dávila; Jose H Donis; Gabriela Arata de Bellabarba; Vanesa Villarroel; Francisco Sanchez; Lisbeth Berrueta; Siham Salmen; Barbara Das Neves
Journal:  Interdiscip Perspect Infect Dis       Date:  2012-10-02
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.